ClinicalTrials.gov
ClinicalTrials.gov Menu

Outcomes of Renal Function in Hepatorenal Syndrome (HRS) Determined By Comparison of Target Mean Arterial Pressure (MAP) of 65 - 70 Mmhg Versus ≥ 85 Mmhg

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02789150
Recruitment Status : Completed
First Posted : June 2, 2016
Last Update Posted : January 16, 2018
Sponsor:
Information provided by (Responsible Party):
Mohamed Saad, University of Louisville

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : January 11, 2018
  Actual Study Completion Date : January 11, 2018